These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3925068)

  • 1. Administration of an anti-interleukin 2 receptor monoclonal antibody prolongs cardiac allograft survival in mice.
    Kirkman RL; Barrett LV; Gaulton GN; Kelley VE; Ythier A; Strom TB
    J Exp Med; 1985 Jul; 162(1):358-62. PubMed ID: 3925068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of anti-interleukin-2 receptor monoclonal antibody on allograft rejection.
    Kirkman RL; Barrett LV; Gaulton GN; Kelley VE; Koltun WA; Schoen FJ; Ythier A; Strom TB
    Transplantation; 1985 Dec; 40(6):719-22. PubMed ID: 3934807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolongation of murine cardiac allograft survival by the anti-interleukin-2 receptor monoclonal antibody AMT-13.
    Kirkman RL; Barrett LV; Koltun WA; Diamantstein T
    Transplant Proc; 1987 Feb; 19(1 Pt 1):618-9. PubMed ID: 3274828
    [No Abstract]   [Full Text] [Related]  

  • 4. Cyclosporine potentiates the immunosuppressive effects of anti-interleukin 2 receptor monoclonal antibody therapy.
    Kupiec-Weglinski JW; Hahn HJ; Kirkman RL; Volk HD; Mouzaki A; DiStefano R; Tellides G; Dallman M; Morris PJ; Strom TB
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):207-16. PubMed ID: 3129841
    [No Abstract]   [Full Text] [Related]  

  • 5. Prolongation of murine skin allograft survival by immunologic manipulation with anti-interleukin 2 receptor antibody.
    Granstein RD; Goulston C; Gaulton GN
    J Immunol; 1986 Feb; 136(3):898-902. PubMed ID: 3079802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapy with monoclonal antibody to interleukin 2 receptor spares suppressor T cells and prevents or reverses acute allograft rejection in rats.
    Kupiec-Weglinski JW; Diamantstein T; Tilney NL; Strom TB
    Proc Natl Acad Sci U S A; 1986 Apr; 83(8):2624-7. PubMed ID: 2939456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific immunosuppressive therapy by monoclonal anti-IL 2 receptor antibody and its synergistic action with cyclosporin.
    Diamantstein T; Volk HD; Tilney NL; Kupiec-Weglinski J
    Immunobiology; 1986 Sep; 172(3-5):391-9. PubMed ID: 3100433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-Tac-H, a humanized antibody to the interleukin 2 receptor, prolongs primate cardiac allograft survival.
    Brown PS; Parenteau GL; Dirbas FM; Garsia RJ; Goldman CK; Bukowski MA; Junghans RP; Queen C; Hakimi J; Benjamin WR
    Proc Natl Acad Sci U S A; 1991 Apr; 88(7):2663-7. PubMed ID: 2011577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-6 receptor signaling disruption prevents cardiac allograft deterioration in mice.
    Iida S; Omoto K; Kanemitsu I; Setoguchi K; Ishida H; Tanabe K; Suzuki T; Tashiro Y; Kishimoto H; Abe R
    Exp Clin Transplant; 2012 Aug; 10(4):375-85. PubMed ID: 22758208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment with anti-interleukin-2 receptor monoclonal antibody.
    Strom TB; Gaulton GN; Kelley VE; Diamanstein T; Kupiec-Weglinski J; Tilney NL; Kirkman RL
    Prog Clin Biol Res; 1986; 224():227-38. PubMed ID: 3099309
    [No Abstract]   [Full Text] [Related]  

  • 11. Administration of anti-interleukin-6 monoclonal antibody prolongs cardiac allograft survival.
    Lei J; He F; Wu M; Zheng X; Chen X; Chen Z
    Transpl Int; 2010 Dec; 23(12):1271-81. PubMed ID: 20646257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective immunosuppression with anti-interleukin 2 receptor-targeted therapy: helper and suppressor cell activity in rat recipients of cardiac allografts.
    Kupiec-Weglinski JW; Padberg W; Uhteg LC; Ma L; Lord RH; Araneda D; Strom TB; Diamantstein T; Tilney NL
    Eur J Immunol; 1987 Mar; 17(3):313-9. PubMed ID: 2952511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional blocking of the interleukin-2 receptor (IL-2R) may be important in the efficacy of IL-2R antibody therapy.
    Tellides G; Dallman MJ; Kupiec-Weglinski JW; Diamantstein T; Morris PJ
    Transplant Proc; 1987 Oct; 19(5):4231-3. PubMed ID: 3118538
    [No Abstract]   [Full Text] [Related]  

  • 14. Anti-interleukin 2 receptor monoclonal antibody therapy in rat recipients of cardiac allografts: the role of antibody isotype.
    Kupiec-Weglinski JW; Di Stefano R; Stunkel KG; Grutzmann R; Theisen P; Araneda D; Tilney NL; Diamantstein T
    Transplant Proc; 1988 Feb; 20(1 Suppl 1):272-5. PubMed ID: 3126574
    [No Abstract]   [Full Text] [Related]  

  • 15. Anti-T cell monoclonal antibodies for in vivo treatment of cardiac allograft rejection in mice.
    Mottram PL; Smyth M; Pietersz GA; Clunie GJ; McKenzie IF
    Transplant Proc; 1989 Feb; 21(1 Pt 1):1020-1. PubMed ID: 2650063
    [No Abstract]   [Full Text] [Related]  

  • 16. Identification of IL 2R+ T cells and macrophages within rejecting rat cardiac allografts, and comparison of the effects of treatment with anti-IL 2R monoclonal antibody or cyclosporin.
    Hancock WW; Lord RH; Colby AJ; Diamantstein T; Rickles FR; Dijkstra C; Hogg N; Tilney NL
    J Immunol; 1987 Jan; 138(1):164-70. PubMed ID: 3097143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Humanized antibody directed to the IL-2 receptor beta-chain prolongs primate cardiac allograft survival.
    Tinubu SA; Hakimi J; Kondas JA; Bailon P; Familletti PC; Spence C; Crittenden MD; Parenteau GL; Dirbas FM; Tsudo M
    J Immunol; 1994 Nov; 153(9):4330-8. PubMed ID: 7930631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolongation of rat cardiac allograft survival by a monoclonal antibody: anti-rat intercellular adhesion molecule-1.
    Kobayashi H; Miyano T; Yamataka A; Yamataka T; Yagita H; Eto H; Ligo Y; Tansyo S; Kojima Y; Tamatani T
    Cardiovasc Surg; 1993 Oct; 1(5):577-82. PubMed ID: 7915626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-10 eliminates anti-CD3 monoclonal antibody-induced mortality and prolongs heart allograft survival in inbred mice.
    Lowry RP; Konieczny B; Alexander D; Larsen C; Pearson T; Smith S; Narula S
    Transplant Proc; 1995 Feb; 27(1):392-4. PubMed ID: 7879034
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of murine cardiac allograft by monoclonal antibodies to IL-2 receptor alpha chain and beta chain.
    Isobe M; Suzuki J; Okubo Y; Horie S; Tanaka T; Miyasaka M; Sekiguchi M
    Transplant Proc; 1997 Jun; 29(4):2301-2. PubMed ID: 9193630
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.